Clinical trial
A Prospective Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients
NCT01604252 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients
- Lead sponsor
- Genentech, Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- June 20, 2012
- Completion date
- April 28, 2017
- Enrollment
- 503 (actual)
- Sites
- 81
Conditions
As the registry lists them; a condition with its own page is linked.